In Vitro and In Vivo Induction of Cytochrome p450: A Survey of the Current Practices and Recommendations: A Pharmaceutical Research and Manufacturers of America Perspective Publication In Vitro and In Vivo Induction of Cytochrome p450: A Survey of the Current Practices and Recommendations: A Pharmaceutical Research and Manufacturers of America Perspective Cytochrome P450 (P450) induction is one of the factors that can affect the pharmacokinetics of a drug…Danielle Pillsbury2009 年 7 月 1 日
The Clinical Utility Index as a Practical Multiattribute Approach to Drug Development Decisions Publication The Clinical Utility Index as a Practical Multiattribute Approach to Drug Development Decisions We identify some innovative approaches to predicting overall patient benefit from investigational drugs to support…Danielle Pillsbury2009 年 7 月 1 日
Assessing the Efficiency of Mixed Effects Modeling in Quantifying Metabolism-based Drug-drug Interactions: Using In Vitro Data as an Aid to Assess Study Power Publication Assessing the Efficiency of Mixed Effects Modeling in Quantifying Metabolism-based Drug-drug Interactions: Using In Vitro Data as an Aid to Assess Study Power The clinical assessment of metabolic drug-drug interactions (mDDI) may involve population-based pharmacokinetic (POPPK) assessment as…Danielle Pillsbury2009 年 7 月 1 日
Physiologically-based Pharmacokinetics (PBPK) Publication Physiologically-based Pharmacokinetics (PBPK) Allometric scaling is widely used to predict human pharmacokinetic parameters from preclinical species, and many…Danielle Pillsbury2009 年 6 月 1 日
In Vitro and In Silico Identification and Characterization of Thiabendazole as a Mechanism-based Inhibitor of CYP1A2 and Simulation of Possible Pharmacokinetic Drug-drug Interactions Publication In Vitro and In Silico Identification and Characterization of Thiabendazole as a Mechanism-based Inhibitor of CYP1A2 and Simulation of Possible Pharmacokinetic Drug-drug Interactions Thiabendazole (TBZ) and its major metabolite 5-hydroxythiabendazole (5OH-TBZ) were screened for potential time-dependent inhibition (TDI) against CYP1A2.…Danielle Pillsbury2009 年 6 月 1 日
Population-based Mechanistic Prediction of Oral Drug Absorption Publication Population-based Mechanistic Prediction of Oral Drug Absorption The bioavailability of drugs from oral formulations is influenced by many physiological factors including gastrointestinal…Danielle Pillsbury2009 年 6 月 1 日
Towards a Quantitative Framework for the Prediction of DDIs Arising from Cytochrome P450 Induction Publication Towards a Quantitative Framework for the Prediction of DDIs Arising from Cytochrome P450 Induction Although CYP induction is not generally considered to be as clinically relevant as CYP inhibition,…Danielle Pillsbury2009 年 5 月 1 日
In Vitro and In Vivo Glucuronidation of Midazolam in Humans Publication In Vitro and In Vivo Glucuronidation of Midazolam in Humans Midazolam (MDZ) is a benzodiazepine used as a CYP3A4 probe in clinical and in vitro studies. A…Danielle Pillsbury2009 年 4 月 1 日
Bioavailability and Tolerability of Intranasal Diazepam in Healthy Adult Volunteers Publication Bioavailability and Tolerability of Intranasal Diazepam in Healthy Adult Volunteers Intranasal therapy has been proposed as an alternative for the management of seizure emergencies. The…Danielle Pillsbury2009 年 4 月 1 日
Utilization of Estimated Physicochemical Properties as an Integrated Part of Predicting Hepatic Clearance in the Early Drug-discovery Stage: Impact of Plasma and Microsomal Binding Publication Utilization of Estimated Physicochemical Properties as an Integrated Part of Predicting Hepatic Clearance in the Early Drug-discovery Stage: Impact of Plasma and Microsomal Binding Rapid prediction of hepatic clearance for drug candidates plays an important role for decision-making in…Danielle Pillsbury2009 年 3 月 1 日